目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
What's New in This Report
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Market Size and Evolution
Chapter- 3: Market Overview
Definition
History of Cancer and Its Management
Causes of Cancer
Types of Cancer-Causing Genes
Immune System and Cancer
Classification of Cancer
Cancer Prevention
Types of Cancer Treatment
Cancer Vaccines
Cancer Vaccines Platform
Chapter- 4: Impact of COVID-19 on the Market
Overview
COVID-19 Impact on Cancer Care
Chapter- 5: Regulatory Aspects
Overview
Regulatory History of Approved Cancer Vaccines
Recalls
Orphan Drug Designation
Fast-Track Designations
Chapter- 6: Market Breakdown by Type
Overview
Therapeutic Vaccines
Prophylactic Vaccines
Chapter- 7: Market Breakdown by Application
Overview
Cancer Vaccines Application in Various Cancers
Prostate Cancer
Liver Cancer
Cervical Cancer
Others
Chapter- 8: Market Breakdown by Region
Introduction
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 9: Industry Structure
Competitive Landscape
Patent Analysis
Pipeline Analysis
Chapter- 10: Current Situation
Overview
Factors Affecting Cancer Vaccines
Challenges in Cancer Vaccines
Chapter- 11: Company Profiles
AMGEN INC.
ANIXA BIOSCIENCES INC.
DENDREON CORP.
ETHERNA
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
IMMUNICUM AB
INOVIO PHARMACEUTICALS INC.
MERCK & CO. INC.
MODERNA INC.
OSE IMMUNOTHERAPEUTICS
PROVIDENCE THERAPEUTICS HOLDINGS INC.
UBIVAC
VACCINOGEN INC.
Chapter- 12: Other International Companies
ADAMIS PHARMACEUTICALS CORP.
ADVAXIS INC.
ALPHAVAX INC.
BELLICUM PHARMACEUTICALS INC.
CANDEL THERAPEUTICS INC.
CELLDEX THERAPEUTICS INC.
CUREVAC AG
GENEXINE INC.
GLOBEIMMUNE INC.
GRADALIS INC.
IMMUNOVATIVE THERAPIES LTD.
ISA PHARMACEUTICALS B.V.
ONCOVIR INC.
SOTIO A.S.
VAXON BIOTECH
Chapter- 13: Appendix A: Acronyms
Table 42 : Abbreviations Used in This Report
